Treatment for Upper Respiratory Tract Infections (URTIs)
Most upper respiratory tract infections (URTIs) are viral in nature and do not require antibiotic treatment. Inappropriate use of antibiotics for URTIs contributes significantly to antibiotic resistance and should be avoided 1, 2.
Diagnostic Approach
When evaluating a patient with URTI symptoms, consider:
- Duration of symptoms (>10 days suggests possible bacterial infection)
- Fever pattern (>38°C for more than 3 days suggests bacterial infection)
- Purulent or colored sputum, especially if persistent for >3 weeks
- Presence of specific symptoms (ear pain, facial pain, sore throat)
Treatment Algorithm
1. Common Cold/Viral URTI
- First-line treatment: Symptomatic management only
- Adequate hydration
- Rest
- Over-the-counter analgesics (acetaminophen, NSAIDs)
- Saline nasal irrigation
- Avoid antibiotics 2
2. Pharyngitis
- If bacterial (GABHS) is suspected:
3. Acute Rhinosinusitis
- Viral (most cases): Symptomatic treatment only
- Bacterial (consider if symptoms >10 days, high fever, or worsening after initial improvement):
4. Exacerbation of Chronic Bronchitis
- Simple chronic bronchitis: Antibiotics not recommended initially, even with fever 1
- If fever persists >3 days or meets Anthonisen criteria (increased dyspnea, increased sputum volume, increased sputum purulence):
- First-line: Amoxicillin 1
- Alternative: First-generation cephalosporins, macrolides, or doxycycline (if penicillin allergy)
5. Chronic Obstructive Bronchitis with Respiratory Insufficiency
- Immediate antibiotic therapy recommended 1
- First-line: Amoxicillin-clavulanate 875/125 mg twice daily 1, 4
- Alternative: Respiratory fluoroquinolones (levofloxacin, moxifloxacin) - reserve for treatment failures 1, 4
Special Considerations
When to Consider Antibiotics
Antibiotics should be considered in URTIs only when:
- Symptoms persist beyond 10 days
- Fever >38°C persists for more than 3 days
- Symptoms worsen after initial improvement
- Patient has specific high-risk factors (elderly, immunocompromised, chronic respiratory disease) 6
High-Risk Patients
For patients >65 years with comorbidities (diabetes, heart failure, hospitalization in previous year, current steroid use):
Common Pitfalls to Avoid
Prescribing antibiotics for viral URTIs: Most URTIs are viral and self-limiting; antibiotics do not shorten duration or reduce symptoms 1, 2
Using colored sputum as sole indicator for antibiotics: Green or yellow sputum alone is not a reliable indicator of bacterial infection unless persistent for >3 weeks 4
Prescribing fluoroquinolones as first-line: Reserve these for treatment failures or specific indications due to resistance concerns 4
Inadequate treatment duration: Complete the full course of antibiotics when prescribed, even if symptoms improve quickly 4
Treating upper respiratory infections with antibiotics to prevent lower respiratory infections: This approach is not effective and contributes to antibiotic resistance 1
By following these evidence-based guidelines, clinicians can ensure appropriate management of URTIs while minimizing unnecessary antibiotic use and its associated consequences.